Lauran Neergaard
The Associated Press
Washington, DC, United States
Contact Lauran
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Lauran:
FDA’s advisers back plan to simplify COVID-19 vaccinations
The FDA’s plan is to call its advisory panel for another meeting in late May or early June to decide if the vaccine recipe needs tweaking — including which virus strain to target. → Read More
FDA’s advisers back plan to simplify COVID-19 vaccinations
The FDA’s plan is to call its advisory panel for another meeting in late May or early June to decide if the vaccine recipe needs tweaking — including which virus strain to target. → Read More
FDA’s advisers back plan to simplify COVID-19 vaccinations
The FDA’s plan is to call its advisory panel for another meeting in late May or early June to decide if the vaccine recipe needs tweaking — including which virus strain to target. → Read More
FDA’s advisers back plan to simplify COVID-19 vaccinations
The FDA’s plan is to call its advisory panel for another meeting in late May or early June to decide if the vaccine recipe needs tweaking — including which virus strain to target. → Read More
FDA’s advisers back plan to simplify COVID-19 vaccinations
The FDA’s plan is to call its advisory panel for another meeting in late May or early June to decide if the vaccine recipe needs tweaking — including which virus strain to target. → Read More
FDA’s advisers back plan to simplify COVID-19 vaccinations
The FDA’s plan is to call its advisory panel for another meeting in late May or early June to decide if the vaccine recipe needs tweaking — including which virus strain to target. → Read More
FDA’s advisers back plan to simplify COVID-19 vaccinations
The FDA’s plan is to call its advisory panel for another meeting in late May or early June to decide if the vaccine recipe needs tweaking — including which virus strain to target. → Read More
FDA’s advisers back plan to simplify COVID-19 vaccinations
The FDA’s plan is to call its advisory panel for another meeting in late May or early June to decide if the vaccine recipe needs tweaking — including which virus strain to target. → Read More
FDA’s advisers back plan to simplify COVID-19 vaccinations
The FDA’s plan is to call its advisory panel for another meeting in late May or early June to decide if the vaccine recipe needs tweaking — including which virus strain to target. → Read More
FDA’s advisers back plan to simplify COVID-19 vaccinations
The FDA’s plan is to call its advisory panel for another meeting in late May or early June to decide if the vaccine recipe needs tweaking — including which virus strain to target. → Read More
New Alzheimer's drug: What to know as Leqembi hits the market
Here are some things to know about the FDA's approval of lecanemab, to be sold under the brand name Leqembi. → Read More
New Alzheimer's drug: What to know as Leqembi hits the market
Here are some things to know about the FDA's approval of lecanemab, to be sold under the brand name Leqembi. → Read More
Making pig livers humanlike in quest to ease organ shortage
EDEN PRAIRIE, Minn. (AP) — The ghostly form floating in a large jar had been the robust reddish-brown of a healthy organ just hours before. Now it’s semitranslucent, white tubes like branches on a tre... → Read More
Could pig livers be the answer to human organ shortages?
Researchers hope to get FDA approval for trials that could pave the way for transplanting modified pig organs into humans. → Read More
Fauci offers parting words as he leaves public office: 'Stick to the science'
Fauci steps down from a five-decade career in public service at the end of the month, one shaped by the HIV pandemic early on and the COVID-19 pandemic to end. → Read More
FDA clears bivalent COVID-19 booster shots for children under 5
The FDA has authorized use of the tweaked shots starting at age 6 months, but just who is eligible depends on how many vaccinations they’ve already had. → Read More
FDA clears updated COVID-19 vaccines for kids younger than age 5
Omicron-targeted booster shots made by Moderna and rival Pfizer already were open to everyone 5 and older. → Read More
FDA clears updated COVID-19 vaccines for kids younger than age 5
Omicron-targeted booster shots made by Moderna and rival Pfizer already were open to everyone 5 and older. → Read More
FDA clears updated COVID-19 vaccines for kids younger than age 5
Omicron-targeted booster shots made by Moderna and rival Pfizer already were open to everyone 5 and older. → Read More
FDA clears updated COVID-19 vaccines for kids younger than age 5
Omicron-targeted booster shots made by Moderna and rival Pfizer already were open to everyone 5 and older. → Read More